Deutsche Bank’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52M | Sell |
1,874,343
-197,896
| -10% | -$477K | ﹤0.01% | 1277 |
|
|
2025
Q1 | $4.58M | Buy |
2,072,239
+835,600
| +68% | +$1.85M | ﹤0.01% | 1280 |
|
|
2024
Q4 | $6.74M | Sell |
1,236,639
-629,496
| -34% | -$3.43M | ﹤0.01% | 1178 |
|
|
2024
Q3 | $15.5M | Buy |
1,866,135
+239,318
| +15% | +$1.99M | 0.01% | 896 |
|
|
2024
Q2 | $11.6M | Buy |
1,626,817
+212,285
| +15% | +$1.52M | 0.01% | 956 |
|
|
2024
Q1 | $12.3M | Hold |
1,414,532
| – | – | 0.01% | 959 |
|
|
2023
Q4 | $9.27M | Buy |
1,414,532
+1,390,023
| +5,671% | +$9.1M | ﹤0.01% | 1028 |
|
|
2023
Q3 | $245K | Sell |
24,509
-1,434,756
| -98% | -$14.3M | ﹤0.01% | 2619 |
|
|
2023
Q2 | $18.1M | Buy |
1,459,265
+1,176,915
| +417% | +$14.6M | 0.01% | 813 |
|
|
2023
Q1 | $3.96M | Buy |
282,350
+206,528
| +272% | +$2.89M | ﹤0.01% | 1335 |
|
|
2022
Q4 | $1.09M | Buy |
75,822
+69,758
| +1,150% | +$998K | ﹤0.01% | 2006 |
|
|
2022
Q3 | $155K | Buy |
6,064
+227
| +4% | +$5.8K | ﹤0.01% | 3071 |
|
|
2022
Q2 | $166K | Buy |
5,837
+1,227
| +27% | +$34.9K | ﹤0.01% | 3248 |
|
|
2022
Q1 | $163K | Sell |
4,610
-19,254
| -81% | -$681K | ﹤0.01% | 3343 |
|
|
2021
Q4 | $1M | Sell |
23,864
-738,893
| -97% | -$31M | ﹤0.01% | 2424 |
|
|
2021
Q3 | $37.4M | Buy |
762,757
+689,015
| +934% | +$33.8M | 0.02% | 698 |
|
|
2021
Q2 | $3.08M | Sell |
73,742
-22,116
| -23% | -$923K | ﹤0.01% | 1852 |
|
|
2021
Q1 | $3.42M | Buy |
95,858
+41,909
| +78% | +$1.49M | ﹤0.01% | 1792 |
|
|
2020
Q4 | $1.51M | Buy |
+53,949
| New | +$1.51M | ﹤0.01% | 2118 |
|